Neprilysin  Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL NEPRILYSIN  INDUSTRY

2.1 Summary about Neprilysin  Industry

2.2 Neprilysin  Market Trends

2.2.1 Neprilysin  Production & Consumption Trends

2.2.2 Neprilysin  Demand Structure Trends

2.3 Neprilysin  Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 TD-0714

4.2.2 STR-324

4.2.3 PL-265

4.2.4 LHW-090

4.2.5 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Acute Heart Failure

4.3.2 Cancer Pain

4.3.3 Hypertension

4.3.4 Alzheimer's Disease

4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 TD-0714

5.2.2 STR-324

5.2.3 PL-265

5.2.4 LHW-090

5.2.5 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Acute Heart Failure

5.3.2 Cancer Pain

5.3.3 Hypertension

5.3.4 Alzheimer's Disease

5.3.5 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 TD-0714

6.2.2 STR-324

6.2.3 PL-265

6.2.4 LHW-090

6.2.5 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Acute Heart Failure

6.3.2 Cancer Pain

6.3.3 Hypertension

6.3.4 Alzheimer's Disease

6.3.5 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 TD-0714

7.2.2 STR-324

7.2.3 PL-265

7.2.4 LHW-090

7.2.5 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Acute Heart Failure

7.3.2 Cancer Pain

7.3.3 Hypertension

7.3.4 Alzheimer's Disease

7.3.5 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 TD-0714

8.2.2 STR-324

8.2.3 PL-265

8.2.4 LHW-090

8.2.5 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Acute Heart Failure

8.3.2 Cancer Pain

8.3.3 Hypertension

8.3.4 Alzheimer's Disease

8.3.5 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 TD-0714

9.2.2 STR-324

9.2.3 PL-265

9.2.4 LHW-090

9.2.5 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Acute Heart Failure

9.3.2 Cancer Pain

9.3.3 Hypertension

9.3.4 Alzheimer's Disease

9.3.5 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Bioprojet SCR

10.1.2 Novartis AG

10.1.3 Pharmaleads SA

10.1.4 Theravance Biopharma Inc

10.2 Neprilysin  Sales Date of Major Players (2017-2020e)

10.2.1 Bioprojet SCR

10.2.2 Novartis AG

10.2.3 Pharmaleads SA

10.2.4 Theravance Biopharma Inc

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Neprilysin  Product Type Overview

Table Neprilysin  Product Type Market Share List

Table Neprilysin  Product Type of Major Players

Table Brief Introduction of Bioprojet SCR

Table Brief Introduction of Novartis AG

Table Brief Introduction of Pharmaleads SA

Table Brief Introduction of Theravance Biopharma Inc

Table Products & Services of Bioprojet SCR

Table Products & Services of Novartis AG

Table Products & Services of Pharmaleads SA

Table Products & Services of Theravance Biopharma Inc

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Neprilysin  Market Forecast (Million USD) by Region 2021f-2026f

Table Global Neprilysin  Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Neprilysin  Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Neprilysin  Market Forecast (Million USD) Share by Demand 2021f-2026f